| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 08/31/2006 | US20060193834 Antiprotozal composition |
| 08/30/2006 | EP1695715A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica |
| 08/30/2006 | EP1694362A1 Improved parasiticide composition |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1479773B1 Mite galectin |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | CN1824323A Doramectin injection fluid containing soyban oil |
| 08/30/2006 | CN1823991A Medicine and food dual purpose Chinese medicine for preventing and treating ascarid and its manufacturing method |
| 08/30/2006 | CN1823955A Medicine and food dual purpose Chinese medicinal preparation for preventing and treating alimentary canal parasile and its manufacturing method |
| 08/30/2006 | CN1823954A Medicine and food dual purpose Chinese medicinal preparation for preventing and treating enterozoon and its manufacturing method |
| 08/30/2006 | CN1272327C Preparation method for sulfadoxine |
| 08/30/2006 | CN1272031C Use of piper betle leaf extractive for preparing medicament against leishmania |
| 08/30/2006 | CN1272017C Method for preparing nano-microballons of Avermectins medicine and usage |
| 08/30/2006 | CN1272003C Sophocarpidine gel preparation and its preparation |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/25/2006 | CA2534927A1 Use of active compounds for the prophylaxis and treatment of parasitic infections in fish |
| 08/24/2006 | WO2006087935A1 Pharmaceutical composition containing phenoxazinium compound as active ingredient |
| 08/24/2006 | US20060189699 Antimicrobial trinervitane derivatives |
| 08/24/2006 | US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | CN1822880A Parasiticidal composition |
| 08/23/2006 | CN1822854A Methods and compositions for controlling ectoparasites |
| 08/22/2006 | US7094391 oral Lime disease vaccination using pure Outer surface protein A specific serum Immunoglobulin A antibodies; immunotherapy |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060182769 purified polypeptide comprising T epitope from a liver-stage specific protein; in vitro diagnosis of malaria by standard detection of the immunological reaction; vaccination against the malaria caused by P. falciparum |
| 08/16/2006 | EP1689698A1 Bis-cationic compounds and use thereof |
| 08/16/2006 | EP1689416A1 Disinfecting composition and methods of making and using same |
| 08/16/2006 | EP1689405A1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance |
| 08/16/2006 | EP1363930B1 A method for generating genetically altered antigens |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1269822C Inhibitors of cruzipain and other cysteine proteases |
| 08/16/2006 | CN1269507C Medication for detoxifying and nourishing saliva and qi |
| 08/16/2006 | CN1269481C Continuous release medicine composition and its preparation method |
| 08/15/2006 | US7091371 Treating an animal for parasites |
| 08/15/2006 | US7091239 DNA polymerase inhibitors, mikanolide and dihydromikanolide |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7090861 Sustained release delivery systems for solutes |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006082030A1 New 4-aminoquinoline derivatives as antimalarials |
| 08/10/2006 | DE102005005397A1 Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms Isolation of N-butyl benzene, synthesis of benzenesulfonamide derivatives as well as using N-butyl benzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostatic hyperplasia and / or prostate carcinoma |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1687312A1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 08/09/2006 | EP1687033A2 Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines |
| 08/09/2006 | EP1687023A2 Use of specific histones for the treatment of parasitic diseases |
| 08/09/2006 | EP1686971A2 Use of haloarylpyrazole compounds in the control of parasite infestation on animals |
| 08/09/2006 | EP1448179B1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1143981B1 Use of n-glycolneuraminic acid and its derivatives for the manufacture of a medicament for the treatment of hiv infections |
| 08/09/2006 | EP1133319B1 Photosensitizer conjugates for targeting intracellular pathogens |
| 08/09/2006 | CN1814618A Japanese schistosome metalloproteuse minic peptide and its screening method and use |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087231 In situ diagnosis of malaria |
| 08/03/2006 | WO2006080311A1 Anthranilamide compound, method for producing same and pest control agent containing same |
| 08/03/2006 | WO2006079642A1 Anthelmintic imidazol-thiazole derivates |
| 08/03/2006 | WO2006079291A1 Artificial synthetic single strand deoxynucleotide and vaccine composition thereof and the use |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | CA2589221A1 Anthelmintic imidazol-thiazole derivates |
| 08/02/2006 | EP1507762B1 Pesticidal pyridinecarboxamide derivatives |
| 08/02/2006 | EP1485389B1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 08/02/2006 | EP1143986B1 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 08/02/2006 | EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |
| 08/02/2006 | CN1267552C Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 08/01/2006 | US7084280 Benzotriazol-1-yl-aminoacetonitrile compounds and their use in the control of parasite disease |
| 08/01/2006 | US7084158 Substituted propargylamines |
| 08/01/2006 | US7084126 Methods and compositions for enhancing cellular function through protection of tissue components |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use |
| 07/27/2006 | WO2006077429A1 Anthelmintic composition |
| 07/27/2006 | WO2006050826A3 Treatment of mastitis with enrofloxacin |
| 07/27/2006 | WO2006037958A3 Treatment of helminth infection by inhibition of tyrosinase |
| 07/27/2006 | WO2006034333A3 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005020894A3 Rifamycin analogs and uses thereof |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166946 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166824 Avermectin and avemectin monosaccharide derivatives substituted in the 4"-or 4'-position having pesticidal properties |
| 07/27/2006 | US20060166341 Method for reproducing pleuromutilins |
| 07/27/2006 | US20060165744 Combination liposomal formulations |
| 07/27/2006 | US20060165731 Vaccines |
| 07/27/2006 | CA2594981A1 Anthelmintic composition |
| 07/27/2006 | CA2562685A1 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 07/26/2006 | EP1683866A2 Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof |
| 07/26/2006 | EP1682125A1 Multiple active agents such as anthelmintics sustained release delivery |